Title	Publication Date	Language	Citations
Imaging of the gastrointestinal tract	2001/01/01
The influence of acquired intelligence on cerebral impairment in the elderly	2001/01/01
Recent research in gastroesophageal reflux disease	2001/01/01
Future trends in the treatment of cognitive disorders	2001/01/01
Unconventional therapies in asthma	2001/01/01
Indigenous drugs and atherosclerosis	2001/01/01
The effects of cytokines on the atherosclerotic process	2002/01/01
The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseases	2002/01/01
New product intros (baloxavir marvoxil (first-in-class); favipiravir; influenza vaccine, quadrivalent; pitavastatin magnesium, voretigene neparvovec-rzyl)	2018/01/01
Guselkumab: human monoclonal antibody against interleukin-23 for moderate to severe psoriasis	2018/01/01
New product intros (besifovir dipivoxil maleate, cenegermin, chenodeoxycholic acid (new indication), dolutegravir sodium/rilpivirine hydrochloride (new combination), hepatitis B vaccine, recombinant (adjuvanted), herpes zoster vaccine (non-live recombinant, AS01B adjuvanted), letermovir, L-glutamine (new indication), olanzapine (new indication), tonogenchoncel-L, vestronidase alfa-vjbk)	2018/01/01
New product intros (abaloparatide, deflazacort (new indication), denosumab (new indication), dimethyl fumarate (new indication), dinalbuphine sebacate, glecaprevir/pibrentasvir (new combination), uselkumab, inotuzumab ozogamicin, neratinib, pembrolizumab (new indication), prasterone, of osbuvir/velpatasvir/voxilaprevir (new combination))	2017/01/01
Notable licensing deals in the biopharma industry in the second quarter of 2017	2017/01/01
New product intros (brigatinib, cerliponase alfa, niraparib hydrochloride, midostaurin, ocrelizumab, valbenazine)	2017/01/01
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA)	2017/01/01
Notable deals in the pharmaceutical industry in the first quarter of 2017	2017/01/01
New product intros (daunorubicin/cytarabine, liposomal (new combination), deutetrabenazine (new indication), enasidenib mesylate, leuprorelin acetate (new indication), teneligliptin hydrobromide/canagliflozin (new combination)	2017/01/01
New product intros (fimasartan/rosuvastatin calcium (new combination), saxagliptin/dapagliflozin (new combination))	2017/01/01
European Society of Cardiology Congress 2017 (August 26-30, 2017 - Barcelona, Spain)	2017/01/01
New product intros (benralizumab, dinutuximab beta, emicizumab-kxwh, evolocumab (new indication), latanoprostene bunod, mepolizumab (new indication), tofacitinib citrate (new indication), umeclidinium bromide/vilanterol trifenate/fluticasone furoate (new combination))	2017/01/01
Notable deals in the pharmaceutical industry in the second quarter of 2016	2016/01/01
Rolapitant hydrochloride: prophylactic treatment for chemotherapy-induced nausea and vomiting	2016/01/01
Notable deals in the pharmaceutical industry in the first quarter of 2016	2016/01/01
Drug Information Association (DIA) - 52nd Annual Meeting (June 26-30, 2016 - Philadelphia, Pennsylvania, USA)	2016/01/01
New product intros (vonicog alfa)	2016/01/01
Transdermal selegiline	2007/01/01
A report from the 26th International Conference on Antiviral Research (May 11-15, San Francisco, California, USA)	2013/01/01
The year's new drugs & biologics, 2013: Part II	2014/01/01
Infliximab for pediatric Crohn's disease	2008/01/01
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure	2008/01/01